Hindsight not needed
Dominic Cumming’s revelations about the Prime Minister and the management of the Covid-19 pandemic made for gripping television, but did they tell us anything we did not already know? If you have doubts look at Coronavirus: 38 days when Britain sleepwalked into disaster, by Sunday Times’ journalists Jonathan Calvert, George Arbuthnot & Jonathan Leake, on April 28th 2020. It’s almost all there, except for the mishandled autumn second wave.
An unnamed Downing Street advisory told the Sunday Times in April 2020: “One day there will inevitably be an inquiry into the lack of preparations during those “lost” five weeks from January 24. There will be questions about when politicians understood the severity of the threat, what the scientists told them and why so little was done to equip the National Health Service for the coming crisis. It will be the politicians who will face the most intense scrutiny”. Roger that!
Last year the University of Glasgow was awarded £38m in funding to create the Precision Medicine Living Lab, a potentially ‘game-changing’ project focused on translating cutting-edge science and innovation into real-world clinical settings. Precision medicine is a medical model that aims to customize healthcare to the individual, with medical decisions, treatments, practices, or products being tailored to a subgroup of patients, instead of a one‐therapy‐fits‐all model. It utilises advanced medical tools such as more precise diagnostics, imaging, genomics and artificial intelligence.
This sounds like a good idea, but like many promising things in medicine, it may yield less benefit than we hope. Glasgow University has the tough job of testing the scientific idea in the real world. If that were all there is to the Precision Medicine Living Lab we could leave it to the boffins. But there is more.
Globally, the precision medicines market is project to reach $134bn by 2025. Working with Glasgow City Council and Glasgow City Region City Deal, the Living Lab is supported by over £22m from industrial partners and an investment of £27.5m from the council and city region deal alongside its UKRI Strength in Places funding. The Living Lab is projected to deliver 446 high-value jobs and £136m Gross Value Added over an 8-year period.
The Living Lab will help companies to develop and commercialise products and processes, encourage business start-ups and offer the NHS substantial savings by implementing Precision Medicine in the UK’s largest hospital. University of Glasgow Principal, Professor Sir Anton Muscatelli, said: …as well as being a game-changer for Precision Medicine in Scotland and the UK, this project will deliver a real impact for the local and national economy. This is an area of the city synonymous with Glaswegian leadership in heavy industry – and it is deeply exciting that the University is helping to lead the way in reimagining this great industrial legacy for the 21st century.”
Precision Medicine in Glasgow means different things to different people. One is an expansion of the medical-industrial complex beyond pharmaceuticals and hardware into new technologies. Another is a tonic for a de-industrialised city, even if there are only 446 ‘high value’ jobs on offer.
Source: National Health Executive 26.06.20
At a recent gathering of NHS Confederation members working on developing Integrated Care Systems a News from Nowhere mole asked a question: is the integration work being hampered by the noise about privatisation? Not in the slightest, said all but one of the senior managers, who denied any such influence on their collaborations. Our mole left the discussion unsure of what is going on. Is the anti-privatisation lobby now thoroughly marginalised and dismissed as conspiracy theorists, or is senior NHS management really that far out of touch?
Source: NfN mole; no names, no pack-drill.
Self-interest always prevails?
Talking of Manchester, one of the highest profile NHS reconfigurations has been “quietly dropped”, according to the Health Service Journal. The proposed consolidation of high-risk general surgery in Greater Manchester, which fought off a judicial review brought by doctors at Wythenshawe Hospital in 2016, will not continue. The plans, which were central to Manchester’s Healthier Together consultation, would have consolidated all high-risk general surgery at four of nine hospitals.
The hospital sites that were set to lose high risk surgery were North Manchester, Wythenshawe, Tameside, Bolton, and Wigan. Those retaining specialist surgical centres were Manchester Royal Infirmary, Salford, Stockport, and Oldham. It was claimed that centralising care into four specialist sites would improve patient outcomes and reduce deaths.
Five years ago, the successful public consultation and victory in the judicial review were seen as central to Greater Manchester’s ability to disrupt the competitive culture of foundation trusts and transform services for patients. However, local sources told the HSJ that some aspects of the reconfiguration had been implemented, such as recruiting additional consultant surgeons and merging some clinical teams. These changes may have improved patient safety and the quality of surgical care enough to weaken the planned reconfigurations.
Comments lodged by (mostly anonymous) observers in the HSJ discussion were characteristically robust. For example:
“This was supposed to be about improving clinical safety and patient outcomes – people in Stockport getting the same access to clinical quality as Central Manchester and Salford offered. Fiefdoms and Consultant jobs seem to have been the determining factor in killing this off”.
And “….the covert and overt lobbying to undermine [Healthier Together] is the perfect example of why they [Providers] will never make the right decisions for health outcomes for a population – self-interest always prevails”.
Source: Lawrence Dunhill Landmark reconfiguration that promised to save 300 lives a year ‘quietly dropped’ Health Services Journal 28 May 2021
Read more News from Nowhere and articles on the NHS in ERA 3 at http://ww